Orthocell Limited (OCC.AX)
Grows cartilage and bone cells to repair damaged joints and tissues in patients.
0.72+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-43.5%
The outlook
OCC.AX is trading near its 52-week lows, well below both its 50- and 200-day moving averages, reflecting downward momentum. Analyst coverage shows an average price target roughly 71% above the current price, though the overall sentiment leans bearish. The stock remains in a weak technical position despite the optimistic target gap.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +71% vs current price
Analyst price target
~12-month · 2 analysts1.23average target+71.3% vs now
Now 0.72
Low 1.19High 1.26
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$194.7M
52-wk high
1.60
52-wk low
0.70
50-day avg
0.76
200-day avg
0.92
Trailing P/E
—